We are live on
!
Find out more
RS
R Squared Portfolio holdings
AUM
$182M
1-Year Est. Return
18.52%
This Fund
S&P 500
This Quarter
Est. Return
+0.01%
1 Year Est. Return
+18.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$103M
AUM Growth
–
Cap. Flow
+$107M
Cap. Flow
% of AUM
104.12%
Top 10 Holdings %
Top 10 Hldgs %
10.53%
Holding
1,571
New
1,571
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$2.59M |
| 2 |
FirstEnergy
FE
|
+$1.2M |
| 3 |
Eaton
ETN
|
+$1.08M |
| 4 |
Consolidated Edison
ED
|
+$1.06M |
| 5 |
Verizon
VZ
|
+$1M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.64% |
| 2 | Technology | 14.58% |
| 3 | Industrials | 13.88% |
| 4 | Consumer Discretionary | 12.94% |
| 5 | Healthcare | 11.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Teekay
TK
$973M
| $26.8K | 0.03% |
+3,870
| New | +$29.8K |
|
752
Banco Santander
SAN
$189B
| $26.8K | 0.03% |
+5,880
| New | +$28.3K |
|
753
James Hardie Industries
JHX
$15B
| $26.8K | 0.03% |
+870
| New | +$30.1K |
|
754
Anika Therapeutics
ANIK
$195M
| $26.7K | 0.03% |
+1,620
| New | +$32K |
|
755
Cabot Corp
CBT
$4.6B
| $26.5K | 0.03% |
+290
| New | +$31.2K |
|
|
ZYXI
756
DELISTED
Zynex
ZYXI
| $26.4K | 0.03% |
+3,290
| New | +$27.1K |
|
757
Cognyte Software
CGNT
$604M
| $26.3K | 0.03% |
+3,040
| New | +$22.9K |
|
758
Guardant Health
GH
$19.9B
| $26.3K | 0.03% |
+860
| New | +$24.2K |
|
759
Howmet Aerospace
HWM
$115B
| $26.2K | 0.03% |
+240
| New | +$26.3K |
|
|
HUT
760
Hut 8
HUT
$13.2B
| $26.2K | 0.03% |
+1,280
| New | +$26.1K |
|
761
The Greenbrier Companies
GBX
$1.59B
| $26.2K | 0.03% |
+430
| New | +$26.2K |
|
762
Dianthus Therapeutics
DNTH
$5.73B
| $26.2K | 0.03% |
+1,200
| New | +$30.9K |
|
763
Simply Good Foods
SMPL
$909M
| $26.1K | 0.03% |
+670
| New | +$24.5K |
|
764
Full House Resorts
FLL
$86.7M
| $25.9K | 0.03% |
+6,350
| New | +$30K |
|
765
Titan Machinery
TITN
$442M
| $25.9K | 0.03% |
+1,830
| New | +$26.5K |
|
|
PLGO
766
Pelagos Insurance Capital
PLGO
$2.15B
| $25.7K | 0.03% |
+1,420
| New | +$26.4K |
|
767
Viridian Therapeutics
VRDN
$2.13B
| $25.7K | 0.03% |
+1,340
| New | +$29.1K |
|
768
Centuri Holdings
CTRI
$2.79B
| $25.7K | 0.03% |
+1,330
| New | +$25.8K |
|
769
Nomura Holdings
NMR
$28.6B
| $25.6K | 0.03% |
+4,430
| New | +$25.1K |
|
770
Syndax Pharmaceuticals
SNDX
$1.88B
| $25.6K | 0.03% |
+1,940
| New | +$33.2K |
|
771
Arcus Biosciences
RCUS
$3.74B
| $25.6K | 0.02% |
+1,720
| New | +$28.1K |
|
|
LKFT
772
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
| $25.6K | 0.02% |
+930
| New | +$25.9K |
|
|
CVGW
773
DELISTED
Calavo Growers
CVGW
| $25.5K | 0.02% |
+1,000
| New | +$27.2K |
|
774
Valley National Bancorp
VLY
$8.01B
| $25.5K | 0.02% |
+2,810
| New | +$27.3K |
|
775
VistaGen Therapeutics
VTGN
$9.27M
| $25.4K | 0.02% |
+8,610
| New | +$24.2K |
|
Similar funds
NED
CFG
CFG
WCM
TFP
AFS
EMB
TCPG
R Squared's Q4 2024 Portfolio in Review
Q4 2024 is the first quarter with a 13F filing on record for R Squared, which disclosed 1,571 positions worth $103M. Its ten largest holdings account for 11% of the portfolio.
Its largest position is Linde: 5,681 shares worth $2.38M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, followed by Technology and Industrials.
- R Squared's largest Q4 2024 buy was Linde: 5,681 shares worth $2.38M.
- R Squared's ten largest holdings make up 11% of its $103M portfolio in Q4 2024.
- R Squared disclosed 1,571 positions in Q4 2024, its first 13F filing on record.
Based on R Squared's 13F filing for Q4 2024, filed 23 Jan 2025.